Cancer is a YMYL (Your Money or Your Life) topic. People use this information to make high-stakes decisions. Our editorial process is designed to keep content accurate, sourced, and understandable — and to make it obvious when something is educational context versus a medical recommendation.
Who writes and reviews content
Articles and cancer-type pages are produced by the CancerInsight editorial team. Statistical figures are checked against NCI SEER Stat Facts and related NCI publications. Research summaries are written from the primary peer-reviewed paper (and, when relevant, FDA labels or ClinicalTrials.gov records), not from secondary blog posts.
Content is published under the byline CancerInsight Editorial Team. Where a page summarizes a clinical trial, the trial name, journal, and year are stated in the article body and listed again under Sources.
What we cite
- National Cancer Institute (NCI) and SEER Program statistics
- Peer-reviewed journals (e.g., NEJM, The Lancet, JCO, Nature)
- FDA drug approvals and labeling where treatment status is discussed
- ClinicalTrials.gov for active study listings
- American Cancer Society and USPSTF guidance when discussing screening intervals
Outbound source links on article pages use rel="nofollow noopener noreferrer" so citation does not pass SEO equity — the goal is transparency for readers, not link schemes.
How we update pages
Cancer-type overview pages are refreshed when SEER annual estimates change or when a practice-changing FDA approval or Phase 3 result materially shifts the treatment landscape. News articles are dated; if a later trial supersedes a finding, we either update the article with a clear revision note or publish a follow-up piece and link between them.
Corrections
If you find a factual error, email contact@cancerinsight.net with the page URL and the correction. We investigate against primary sources and, when warranted, update the page promptly. Significant corrections are noted on the page.
What we are not
- We do not provide diagnoses, prescriptions, or personalized treatment plans.
- We do not accept payment from hospitals or drug companies to alter rankings or recommendations.
- We do not invent statistics. If a figure is an estimate, we say so.
Advertising and funding
Patient navigation callbacks are free to the user. If sponsorship or affiliate relationships are ever introduced, they will be disclosed on the relevant pages and will not change clinical facts drawn from NCI, FDA, or peer-reviewed literature.
About CancerInsight · Contact · News & Insights
Medical Disclaimer: Educational content only. Always consult a qualified healthcare provider for decisions about screening, diagnosis, and treatment.